subcutaneous self-administration of synthetic gonadotrophin-releasing hormone 500 mug eight-hourly for up to one year by 12 male patients ( five prepubertal ) with clinical hypogonadism due to hypothalamic or pituitary disease resulted in the synthesis and continued release of luteinizing hormone ( lh ) and follicle-stimulating hormone ( fsh ) .
C0018061
gonadotrophin
C0733758
follicle-stimulating hormone